GenSpera Inc. – “Expanded Intellectual Property for Thapsigargin Production”

NEW YORK, NY / ACCESSWIRE / July 14, 2015 / GenSpera Inc. (OTCQB: GNSZ) today published a new blog post on The Chairman’s Blog, written by the Company’s chief executive officer, Craig Dionne, Ph.D. TheChairmansBlog.com is an exclusive online media publication that enables key executive officers a unique platform to share insights about their company and industry trends.

Dr. Dionne reflects on how the Company’s strategic partner Phyton Biotech, who had its patent application, “Production of Thapsigargins by Thapsia Cell Suspension Culture” published by the World Intellectual Property Organization (WIPO), can help GenSpera discover improved, potentially commercial-scale, production methods. “Such cell lines offer advantages of scalability, sustainability, and reproducibility that could replace our farming efforts in the future,” stated Dionne. Read the full blog post from Dr. Dionne onTheChairmansBlog.com. (http://www.thechairmansblog.com/genspera/craig-dionne/expanded-intellectual-property-for-thapsigargin-production/).

About GenSpera

GenSpera Inc. is a San Antonio-based biotech company that unlocks conventional thinking to conceive, design, and develop cancer therapies. GenSpera’s technology platform combines a powerful, plant-derived cytotoxin (thapsigargin) with a patented prodrug delivery system that provides for targeted release of drug candidates within tumors. GenSpera’s lead drug candidate, mipsagargin, was granted Orphan Drug designation by the U.S. Food and Drug Administration (FDA) in 2013 for evaluation in patients with hepatocellular carcinoma (liver cancer).

For additional information on GenSpera, visit www.genspera.com and connect on Twitter, LinkedIn, Facebook, YouTube and Google+.

About TheChairmansBlog.com

TheChairmansBlog.com is an exclusive, online media publication where publicly and privately held firms alike share insights about their companies and industries. TheChairmansBlog.com enables upper tier management to discuss issues that are of importance to their stakeholders, shareholders, and interested parties in an informal environment. www.thechairmansblog.com

SOURCE: TheChairmansBlog.com

ReleaseID: 430534